Please provide your email address to receive an email when new articles are posted on . The single-center, dose-escalation study included 12 patients (median age, 9 years; 58% female) with newly ...
To understand the ethical dilemmas that beset this issue of biopsy in children with newly diagnosed diffuse intrinsic pontine glioma, one must understand both the history behind it and the current ...
Like other tumors that arise in midline structures of the brain, most DIPGs are histone H3-mutated tumors that harbor H3K27M mutations. DIPG typically originates in the ventral pons, which is the ...
Michelle and Cory Green from Washington state share how their daughter lost her battle with one of the rarest childhood cancers. In 2021, Alivia was diagnosed with diffuse intrinsic pontine glioma. In ...
Oblato plans to evaluate OKN-007 for diffuse intrinsic pontine glioma in a phase 1/2 trial this year. The Food and Drug Administration (FDA) has fast tracked an investigational therapy for diffuse ...
Diffuse intrinsic pontine glioma (DIPG) is an almost universally fatal brain pediatric tumor and the only tumor indication where palliative radiotherapy is the current standard of care. Although ...
HOUSTON, Texas (KTRK) -- Six months ago, we told you about a young woman who was diagnosed with a deadly brain tumor only found in children. She has been on a journey with Houston Methodist Hospital ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio OKN-007 received FDA fast track ...
Diffuse intrinsic pontine gliomas (DIPGs), with a median survival of 9 months, represent the biggest therapeutic challenge in pediatric neuro-oncology. Despite many clinical trials, no major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results